Ledger.Open graph →
SEC Form D · Amendment · filed April 21, 2022

Novosteo Inc

Offering
$17.7M
Sold
$17.7M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
WEST LAFAYETTE, IN
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Philip S. Low, Ph.D · West Lafayette, INExec · DirectorAlex S. Andrianopoulos · West Lafayette, INDirectorDaniel S. Hasler · West Lafayette, INDirectorDirk Thye, M.D · West Lafayette, INExec · DirectorDavid J. Lamond · West Lafayette, INDirectorCopernico Capital Partners (Bermuda) Ltd · Hamilton, BermudaExec · DirectorJay R. Schmelter · Austin, TXDirectorOcean Arete Limited · Central, Hong KongDirectorLaura S. Gilham · Dallas, TXExec · DirectorWilliam J. Rutter · Norwood, MADirectorToshiyuki Okayasu · Tokyo, M0Exec · DirectorRicky Sim · Tokyo, M0DirectorChris Asimakis · Toronto, Ontario, CanadaDirectorPeter J. Loughran · Chicago, ILExec · DirectorDavid J. Lamond · West Lafayette, INDirectorWilliam J. Rutter · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗